关注
H. Umit Kaniskan
H. Umit Kaniskan
Mount Sinai School of Medicine Department of Pharmocological Sciences
在 mssm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Advancing targeted protein degradation for cancer therapy
B Dale, M Cheng, KS Park, HÜ Kaniskan, Y Xiong, J Jin
Nature Reviews Cancer 21 (10), 638-654, 2021
3052021
Inhibitors of protein methyltransferases and demethylases
HU Kaniskan, ML Martini, J Jin
Chemical reviews 118 (3), 989-1068, 2018
2722018
Light-induced control of protein destruction by opto-PROTAC
J Liu, H Chen, L Ma, Z He, D Wang, Y Liu, Q Lin, T Zhang, N Gray, ...
Science advances 6 (8), eaay5154, 2020
2532020
A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases
MS Eram, Y Shen, MM Szewczyk, H Wu, G Senisterra, F Li, KV Butler, ...
ACS chemical biology 11 (3), 772-781, 2016
2402016
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
S Vatansever, A Schlessinger, D Wacker, HÜ Kaniskan, J Jin, MM Zhou, ...
Medicinal research reviews 41 (3), 1427-1473, 2021
1892021
Cancer selective target degradation by folate-caged PROTACs
J Liu, H Chen, Y Liu, Y Shen, F Meng, HU Kaniskan, J Jin, W Wei
Journal of the American Chemical Society 143 (19), 7380-7387, 2021
1372021
TF-PROTACs enable targeted degradation of transcription factors
J Liu, H Chen, HU Kaniskan, L Xie, X Chen, J Jin, W Wei
Journal of the American Chemical Society 143 (23), 8902-8910, 2021
1342021
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
KP Bhat, H Ümit Kaniskan, J Jin, O Gozani
Nature Reviews Drug Discovery 20 (4), 265-286, 2021
1342021
Selective inhibitors of protein methyltransferases
HU Kaniskan, KD Konze, J Jin
Journal of medicinal chemistry 58 (4), 1596-1629, 2015
1342015
Transformative network modeling of multi-omics data reveals detailed circuits, key regulators, and potential therapeutics for Alzheimer’s disease
M Wang, A Li, M Sekiya, ND Beckmann, X Quan, N Schrode, ...
Neuron 109 (2), 257-272. e14, 2021
1222021
A potent, selective and cell‐active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)
HÜ Kaniskan, MM Szewczyk, Z Yu, MS Eram, X Yang, K Schmidt, X Luo, ...
Angewandte Chemie 127 (17), 5255-5259, 2015
1152015
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
S Scheer, S Ackloo, TS Medina, M Schapira, F Li, JA Ward, AM Lewis, ...
Nature communications 10 (1), 19, 2019
1112019
Discovery of a potent, selective, and cell-active dual inhibitor of protein arginine methyltransferase 4 and protein arginine methyltransferase 6
Y Shen, MM Szewczyk, MS Eram, D Smil, HU Kaniskan, ...
Journal of medicinal chemistry 59 (19), 9124-9139, 2016
802016
Harnessing the E3 ligase KEAP1 for targeted protein degradation
J Wei, F Meng, KS Park, H Yim, J Velez, P Kumar, L Wang, L Xie, H Chen, ...
Journal of the American Chemical Society 143 (37), 15073-15083, 2021
792021
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
X Yu, D Li, J Kottur, Y Shen, HS Kim, KS Park, YH Tsai, W Gong, J Wang, ...
Science translational medicine 13 (613), eabj1578, 2021
782021
Asymmetric multicomponent [C+ NC+ CC] synthesis of highly functionalized pyrrolidines catalyzed by silver (I)
P Garner, HÜ Kaniskan, J Hu, WJ Youngs, M Panzner
Organic letters 8 (17), 3647-3650, 2006
682006
Chemical probes of histone lysine methyltransferases
HU Kaniskan, J Jin
ACS chemical biology 10 (1), 40-50, 2015
612015
Structure–activity relationship studies for enhancer of zeste homologue 2 (EZH2) and enhancer of zeste homologue 1 (EZH1) inhibitors
X Yang, F Li, KD Konze, J Meslamani, A Ma, PJ Brown, MM Zhou, ...
Journal of medicinal chemistry 59 (16), 7617-7633, 2016
572016
Folate-guided protein degradation by immunomodulatory imide drug-based molecular glues and proteolysis targeting chimeras
H Chen, J Liu, HU Kaniskan, W Wei, J Jin
Journal of medicinal chemistry 64 (16), 12273-12285, 2021
432021
Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site
AW Kahsai, J Cui, HU Kaniskan, PP Garner, G Fenteany
Journal of biological chemistry 283 (36), 24534-24545, 2008
432008
系统目前无法执行此操作,请稍后再试。
文章 1–20